Eduardo Stancanelli
NewGen Therapeutics (United States)
ORCID: 0000-0002-6006-2209Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Degeneracy of the Antithrombin Binding Sequence in Heparin: 2‐O‐Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid”.
Eduardo Stancanelli, Zhangjie Wang, Maurice Petitou, Jian Liu, Marco Guerrini +1 more
Andrea M. Kaminski, Zhangjie Wang, Eduardo Stancanelli, Yongmei Xu, Vijayakanth Pagadala +6 more
Wei Liu, Rylee Wander, Jine Li, Zhangjie Wang, Katelyn Arnold +8 more
Yanan Zhu, Guowei Su, Jing Zhao, Ashely Canning, James M. Gibson +9 more
Yanan Zhu, Guowei Su, Jing Zhao, Ashely Canning, James M. Gibson +9 more
Wei Liu, Guowei Su, Vijay Padagala, Jian Liu, Eduardo Stancanelli
Wei‐Chun Tang, Eduardo Stancanelli, Eun-Kyung Jung, Zulfeqhar A. Syed, Vijayakanth Pagadala +13 more
Dixy E. Green, Katelyn Arnold, Jian-Xiang Zhang, Deyu Kong, Paul L. DeAngelis +2 more
Juno A. Krahn, Elizabeth Viverette, Robert Dutcher, Vijayakanth Pagadala, Mario J. Borgnia +3 more
Paul L. DeAngelis, Deyu Kong, Dixy E. Green, Katelyn Arnold, Eduardo Stancanelli +2 more